EltaMD Launches Limited-Edition Sunscreen to Support Skin Cancer Prevention Initiative
EltaMD's Limited-Edition UV Daily SPF 40: A Step Towards Skin Cancer Awareness
In celebration of Skin Cancer Awareness Month, EltaMD, the market leader in dermatologist-recommended professional sunscreens, is launching a limited-edition UV Daily Broad-Spectrum SPF 40. This new product combines essential sun protection with a unique design aimed at stimulating discussions about the importance of year-round sun care.
Under the initiative dubbed “Buy One, Give One”, for each limited-edition sunscreen sold, one is donated to the Melanoma Research Foundation, with an expected contribution of up to $1 million in retail value. This generous effort strives to improve sun protection accessibility and reinforces the vital habit of daily sun safety practices, particularly in combating skin cancer.
To enhance the initiative, EltaMD has collaborated with artist Lucy Kirk, known for her vibrant and expressive artwork. Kirk’s designs, which encapsulate the essence of “living freely under the sun,” turn the sunscreen into a collectible item, promoting an uplifting attitude towards SPF use. The collaboration aims to remind consumers of the importance of protecting their skin every day.
Echo Sandburg, Chief Marketing Officer of CP Skin Health US, stated, “Our focus at EltaMD isn't only on providing sun protection, but on transforming public perception of sun care. By coupling our campaign with a purpose-driven approach, we hope this vibrant packaging serves as a daily visual reminder on why sunscreen is essential.” The limited-edition UV Daily merges a trusted formula with an appealing aesthetic, encouraging consumers to foster better sun-care habits.
EltaMD’s initiative stems from its long-standing partnership with the Melanoma Research Foundation, established in 2021. This collaboration has focused on awareness initiatives, community activities, and educational programming, all marked by their common goal: promoting early detection and prevention of skin cancer.
Kyleigh LiPira, CEO of the Melanoma Research Foundation, expressed pride in this partnership, stating, “By merging educational outreach with actionable steps, we can significantly boost daily sun protection habits, which can lead to notable reductions in skin cancer rates.” EltaMD’s ongoing dedication to skin cancer education expands beyond just one month; it is woven into their brand ethos. Alongside this initiative, the company actively interacts with dermatologists to emphasize the importance of regular skin checks and sun safety education.
Moreover, EltaMD supports mobile skin cancer screening programs, which further contribute to skin health awareness. The limited-edition sunscreen, featuring the same reliable formulation of UV Daily Broad-Spectrum SPF 40, will be available starting May 1, 2026, at a price point of $41 through EltaMD’s website and selected professional partners—while supplies last.
Founded in 1882, EltaMD has built a legacy based on healing formulations for sensitive skin. The objective has transitioned to becoming the foremost authority in sun care, highlighted by the fact that dermatologists recommend EltaMD products more than any other professional sunscreen brand.
With the latest launch, EltaMD® reiterates its commitment not only to effective sun protection but to changing how society approaches skin care. By driving awareness, education, and tangible outcomes through this initiative, EltaMD proves its role as a leader in the industry and a guardian of skin health.